News

Juxtapid, which is a supplement to fat reduction treatments also includes availability of LDL apheresis, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B)

Tamiflu works by blocking the ability of the virus to replicate in the body thereby inhibiting the duration and severity of influenza. With the approval, Tamiflu becomes the

The trial will evaluate the safety and pharmacokinetic profile of single and multi-dose administration of IW-2143, which was discovered by Bionomics, in healthy volunteers. Bionomics CEO and managing

The data analysis failed to detect an effect of davunetide on either the Progressive Supranuclear Palsy Rating Scale and the Schwab and England Activities of Daily Living. The

The study aims to compare the safety and efficacy of ocular iontophoresis with dexamethasone phosphate ophthalmic solution (EGP-437) in relation to topically applied prednisolone acetate (1%) ophthalmic suspension

Iwicki comes with more than 23 years of experience in the pharmaceutical industry with experience in managing different stages of drug development and in multiple therapeutic areas. Prior

Sarepta Therapeutics president and CEO Chris Garabedian said the agreement will lead to development of new treatment options for influenza with new mechanisms of action with limitations of

The patents cover company’s tamper-resistant platforms, designed to resist dose dumping of orally delivered opioids and may sequester and bring down drug release of a drug, which has

According to the deal, Yuhan can leverage CEVEC’s CAP-T and CAP cell expression systems in the production and development of a range of therapeutic proteins. CEVEC CEO Wolfgang